Algin and Magnesium oxide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Algin (algin) and Magnesium oxide (magnesium). Common drug interactions include febrile neutropenia among females and hypomagnesaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Algin and Magnesium oxide. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Algin?

Algin has active ingredients of algin. eHealthMe is studying from 1,584 Algin users. Check the latest studies of Algin.

What is Magnesium oxide?

Magnesium oxide has active ingredients of magnesium. It is often used in migraine. eHealthMe is studying from 19,022 Magnesium oxide users. Check the latest studies of Magnesium oxide.



On Jul, 18, 2026

55 people who take Algin and Magnesium oxide together, and have interactions are studied.

Algin and Magnesium oxide drug interactions.

What are the common drug interactions of Algin and Magnesium Oxide, by gender? *:

female:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Platelet count decreased
  3. Pyrexia (fever)
  4. Diarrhoea
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Stomatitis (inflammation of mucous membrane of mouth)
  7. Abdominal pain upper
  8. Anaemia (lack of blood)
  9. Arthralgia (joint pain)
  10. Back pain

male:

  1. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  2. Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
  3. Pneumonia
  4. Leukopenia (less number of white blood cells in blood)
  5. Oral candidiasis (fungal infection of mouth)
  6. Pneumomediastinum (air is present in the mediastinum)
  7. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  8. Cardiac arrest
  9. Cholangitis (infection of the bile duct)
  10. Pyrexia (fever)

What are the common drug interactions of Algin and Magnesium Oxide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal pain upper
  2. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  3. Anaemia (lack of blood)
  4. Arthralgia (joint pain)
  5. Back pain
  6. Depression
  7. Diarrhoea
  8. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  9. Haemorrhage (bleeding)
  10. Herpes zoster

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Rash
  4. Upper respiratory tract infection
  5. Weight decreased

40-49:

  1. Cerebral infarction (less blood supply to brain resulting tissue damage)
  2. Jaundice cholestatic
  3. Blood pressure increased
  4. Engraft failure
  5. Pyrexia (fever)
  6. Rash
  7. Stenotrophomonas infection
  8. Escherichia sepsis (bacterial infection by escherichia coli)
  9. Therapeutic response decreased (less preventive response)

50-59:

  1. Hypotension (abnormally low blood pressure)
  2. Iron deficiency anaemia
  3. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

60+:

  1. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  2. Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
  3. Platelet count decreased
  4. Pneumonia
  5. Stomatitis (inflammation of mucous membrane of mouth)
  6. Bone marrow failure
  7. Cough
  8. Leukopenia (less number of white blood cells in blood)
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

What are the existing conditions these people have? *

  1. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 12 people, 21.82%
  2. Constipation: 12 people, 21.82%
  3. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 9 people, 16.36%
  4. Pain: 7 people, 12.73%
  5. Indigestion: 7 people, 12.73%
  6. Abdominal Pain: 6 people, 10.91%
  7. Bone Marrow Conditioning Regimen: 5 people, 9.09%
  8. Nausea (feeling of having an urge to vomit): 5 people, 9.09%
  9. Febrile Neutropenia (fever with reduced white blood cells): 5 people, 9.09%
  10. Gastroesophageal Cancer: 5 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Algin and Magnesium oxide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Algin and Magnesium oxide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Algin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Magnesium oxide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Algin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Magnesium oxide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on algin and magnesium (the active ingredients of Algin and Magnesium oxide, respectively), and Algin and Magnesium oxide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: